Detalhe da pesquisa
1.
Modulating the therapeutic response of tumours to dietary serine and glycine starvation.
Nature
; 544(7650): 372-376, 2017 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28425994
2.
Corrigendum: Modulating the therapeutic response of tumours to dietary serine and glycine starvation.
Nature
; 548(7665): 122, 2017 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28770843
3.
Loss of N-WASP drives early progression in an Apc model of intestinal tumourigenesis.
J Pathol
; 245(3): 337-348, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29672847
4.
A novel mouse model of testicular granulosa cell tumors.
Mol Hum Reprod
; 24(7): 343-356, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788434
5.
Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
Reprod Biol Endocrinol
; 15(1): 94, 2017 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221447
6.
Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.
Am J Pathol
; 180(6): 2214-21, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22469842
7.
The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
Pancreatology
; 13(3): 191-5, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23719586
8.
The human NUPR1/P8 gene is transcriptionally activated by transforming growth factor ß via the SMAD signalling pathway.
Biochem J
; 445(2): 285-93, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22738338
9.
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
PLoS Genet
; 5(7): e1000575, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19629168
10.
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth.
Cancer Res
; 82(1): 90-104, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737214
11.
Epithelial TGFß engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.
Nat Commun
; 13(1): 7551, 2022 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477656
12.
Oncogenic BRAF, unrestrained by TGFß-receptor signalling, drives right-sided colonic tumorigenesis.
Nat Commun
; 12(1): 3464, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103493
13.
A rapid strategy to detect the recombined allele in LSL-TßRICA transgenic mice.
Genesis
; 48(9): 559-62, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20645310
14.
Generation of a conditional Flpo/FRT mouse model expressing constitutively active TGFß in fibroblasts.
Sci Rep
; 10(1): 3880, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127548
15.
Glandular defects in the mouse uterus with sustained activation of TGF-beta signaling is associated with altered differentiation of endometrial stromal cells and formation of stromal compartment.
PLoS One
; 13(12): e0209417, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550590
16.
Author Correction: Epithelial TGFß engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features.
Nat Commun
; 14(1): 522, 2023 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720858
17.
TGFß inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.
Sci Transl Med
; 10(454)2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30111642
18.
TGFß pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.
Cell Death Differ
; 24(10): 1681-1693, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622298
19.
Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis.
Cell Mol Gastroenterol Hepatol
; 4(2): 263-282, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28752115
20.
Constitutively active transforming growth factor ß receptor 1 in the mouse ovary promotes tumorigenesis.
Oncotarget
; 7(27): 40904-40918, 2016 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27344183